Ethnic Diversity and Warfarin Pharmacogenomics
Warfarin has remained the most commonly prescribed vitamin K oral anticoagulant worldwide since its approval in 1954. Dosing challenges including having a narrow therapeutic window and a wide interpatient variability in dosing requirements have contributed to making it the most studied drug in terms...
Saved in:
Main Authors: | Innocent G. Asiimwe (Author), Munir Pirmohamed (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
by: Saaket Agrawal, et al.
Published: (2020) -
Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023) -
Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity
by: L. McEvoy, et al.
Published: (2021) -
The Influence of Ethnicity on Warfarin Dosage Requirements in the Chilean Population
by: Valeska Subiabre, MsCs, et al.
Published: (2015) -
Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
by: Carolina eMalta Hansen, et al.
Published: (2012)